Leo Pharma chairman: "In the long term, we will probably have fewer employees"

The pharmaceutical company's ownership circle, including Nordic Capital, is accelerating the transformation of Leo Pharma, and according to Chairman of the Board Jesper Brandgaard this could mean fewer employees in the long term.

Photo: Leo Pharma.

Leo Pharma's transformation is moving up a gear, and according to Chairman of the Board Jesper Brandgaard, this could have consequences for the company's staff, which today counts 5,800 people, reports Danish business daily Børsen.

"What the count will be, time will tell. We don't have a specific target we have to reach. In the long term, we will probably have fewer employees," Brandgaard tells Børsen.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs